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Activins are members of the transforming growth factor b (TGFb) superfamily, which comprises a growing group of dimeric
proteins. TGFb and several other members of this superfamily are known to play an important role in wound healing.
However, expression of activin during wound healing has not been demonstrated so far. In this study we have analyzed
the expression pattern of activin and activin receptors in normal and wounded skin. We found a large induction of activin
A and a minor induction of activin B mRNA expression 1 day after skin injury and high expression levels of activin A and
B were found within the ®rst 7 days after wounding. At 13 days after injury, expression of activin A mRNA had returned
to the basal level, whereas high levels of activin B persisted. In situ hybridization studies revealed expression of activin
A in the granulation tissue below the wound and activin B in the hyperproliferative epithelium at the wound edge and in
the migrating epithelial tongue. All known types of activin receptors as well as the activin binding protein follistatin were
expressed in normal and wounded skin. However, no signi®cant induction of receptor gene expression was seen during the
repair process. The distribution of activins and activin receptors in the wound suggests multiple autocrine and paracrine
activities of the ligands during wound healing. Our data provide evidence for a novel function of activin and indicate that
Ðbesides TGFbs themselvesÐother members of this superfamily might also play an important role in tissue repair.
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INTRODUCTION The biological activity of activins is mediated by hetero-
meric complexes of two different receptor types: the type I
The transforming growth factor (TGF) b family of pro- receptors (also called activin receptor-like kinases (Alk) 2
teins comprises a large group of structurally related proteins and 4) and the type II receptors which are transmembrane
which includes several types of TGFb, bone morphogenetic serine/threonine kinases (for review, see Mathews and Vale,
proteins, Mullerian inhibiting substance, and also activins 1993). It has been shown that the presence of both types
and inhibins. All these molecules regulate various cell func- of receptor is essential for all tested biological responses
tions, including proliferation and differentiation (for review, (Mathews and Vale, 1991, 1993; Attisano et al., 1992, 1993;
see Massague, 1990). Like the other members of the TGFb ten Dijke et al., 1994; Wrana et al., 1994). Furthermore,
family, activins are dimeric proteins, composed of disul- an activin binding proteinÐfollistatinÐhas been identi®ed
phide-linked bA or bB subunits. Three different forms of which acts as an activin antagonist in vitro. Its in vivo
activin have been identi®ed in vivo: the homodimeric ac- function is currently under debate. It may function in vivo
tivin A (bAbA) and activin B (bBbB) variants and the hetero- to present activins to their receptors (Esch et al., 1987; Na-
dimeric activin AB (bAbB). Inhibins are heterodimers of bA kamura et al., 1990; for review, see Michel et al., 1993)
or bB chains with a common a subunit and are designated but inhibition of activin binding to the type II receptor by
inhibin A (abA) and inhibin B (abB), respectively (reviewed follistatin might also occur (D. Huylebroeck, personal com-
by Massague, 1990; Vale et al., 1990). munication).
Activin has been shown to affect growth and differentia-
tion of many different target cells. Thus, it increases the1 To whom correspondence should be addressed. Fax: 089-8578-
2814. number of gonadotrophs in pituitary and modulates differ-
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entiation of ovarian granulosa cells (reviewed by Mayo, et al., 1995). These ®ndings suggested a role of activin in the
development of skin and hair. This hypothesis was further1994). Furthermore, activin A modulates differentiation and
survival of neuronal cells (Hashimoto et al., 1990; Schubert supported upon analysis of transgenic mice which are de®-
cient in the activin binding protein follistatin (Matzuk etet al., 1990), enhances differentiation of megakaryocytes
and erythroid cells (Nishimura et al., 1991; Eto et al., 1987), al., 1995b). These mice had abnormal whisker development
and hyperkeratotic skin, resembling the skin of transgenicand induces mesoderm formation during early development
(Smith et al., 1990; van den Eijnden- van Raaij et al., 1990; mice with directed overexpression of TGF-b1 in the epider-
mis (Sellheyer et al., 1993).Thomson et al., 1990).
Recent studies using transgenic animals have provided The results of these studies lead us to further analyze the
expression and function of activin in the skin. Due to thenew insights into the in vivo function of activin and inhibin
in mammalian development. Targeted disruption of the in- selective expression of activin in embryonic skin we specu-
lated that it might be reexpressed during wound healing.hibin a chain caused tumor formation in the gonads andÐ
after removal of these organsÐalso in the adrenals (Matzuk Here we show that both activin A and activin B expression
are strongly induced in different areas of the wound, sug-et al., 1992, 1994). These ®ndings demonstrate a role of
inhibin in tumor suppression. Whereas the activin/inhibin gesting an important role of activin in skin repair.
bB subunit disruption caused only mild phenotypic abnor-
malities (Vassalli et al., 1994; Schrewe et al., 1994), mice
lacking the bA chain had defects in craniofacial develop- MATERIALS AND METHODS
ment and died within 24 hr after birth (Matzuk et al.,
Animals. Female Balb/c mice (8±12 weeks old) were obtained1995a). Interestingly, these mice also lacked whiskers and
from the animal care facility of the Max-Planck-Institute of Bio-the whisker follicles were abnormal (Matzuk et al., 1995a).
chemistry, Martinsried. The animal care facility was maintainedThis is consistent with previous ®ndings in which activin
by professionals who followed federal guidelines and all proceduresbA expression was detected in the mesenchyme of the hair were approved by the Local Government of Bavaria (Permissionfollicle (Roberts et al., 1991; Roberts and Barth, 1994). Fur-
No. 211-2531-16/93).
thermore, expression of this gene had been found in the Wounding and preparation of wound tissues. Two indepen-
developing hair bulb and also in the dermal layer of embry- dent wound healing experiments were performed. For every experi-
onic skin but not of newborn or adult skin (Roberts et al., ment 20 animals were anesthesized by intraperitoneal injection
1991). In addition to activin, activin type I receptors (Alk- of avertin. The animals' backs were shaved and wiped with 30%
isopropyl alcohol, and six full-thickness wounds (6 mm diameter,2 and Alk-4) are expressed in whisker follicles (Verschueren
FIG. 1. Expression of activin, inhibin, activin receptors, and follistatin in the dermis and in the epidermis of mouse tails. Mouse tail
skin was incubated for 30 min at 377C in a solution of 2 M NaBr. Epidermis was subsequently separated from the dermis and used for
isolation of total RNA. 50 mg RNA from both compartments of the skin was analyzed by RNase protection assay for expression of the
different genes of the activin/activin receptor family as indicated. 1000 cpm of the hybridization probe was loaded in the lane labeled
``probe'' and used as a size marker. 50 mg tRNA was used as a negative control. D, dermis; E, epidermis. The gels were exposed for 10 hr
(ARI, ARII), 2 days (bA , bB , ARIB, follistatin), or 7 days (inhibin a, ARIIB).
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DNA templates. Templates for murine activin and inhibin and
for the activin type I receptors were generated by PCR using primers
corresponding to the published murine or human sequences. The
ampli®ed fragments were as follows: a 148-bp fragment correspond-
ing to nucleotides 173±320 of the activin bA cDNA (Albano et al.,
1993), a 212-bp fragment corresponding to nucleotides 160±371 of
the activin bB cDNA (Albano et al., 1993), a 289-bp fragment of
the inhibin a chain cDNA (kindly provided by J. van den Eijnden-
van Raaij), a 461-bp fragment corresponding to nucleotides 1±461
of the 5*-end of the activin receptor I (Alk-2) cDNA (kindly provided
by D. Huylebroeck), a 170-bp fragment corresponding to the trans-
membrane region of the activin receptor IB (Alk-4) cDNA (ten Dijke
et al., 1993; Carcamo et al., 1994), and a 320-bp fragment corre-
sponding to nucleotides 510±830 of the follistatin cDNA (Albano
et al., 1994; kindly provided by J. van den Eijnden- van Raaij).
The 320-bp fragment encoding the carboxy terminus of the murine
activin receptor II cDNA and the 200-bp fragment encoding the
carboxy terminus of the murine activin receptor IIB cDNA were
subcloned from the corresponding full-length cDNAs (Q.H., unpub-
lished data).
In situ hybridization. Antisense riboprobes were made by in
vitro transcription with T3, T7, or SP6 RNA polymerases and 35S-
labeled UTP. The murine activin bA and bB cDNA fragments de-
scribed above were used as templates for synthesis of sense and
antisense transcripts. In situ hybridization was performed on 6-mm
paraf®n sections as described by Wilkinson et al. (1987), with the
following modi®cations: The hybridization temperature was 507C
and the high-stringency wash was performed at 557C. After hybrid-
ization, sections were coated with NTB2 nuclear emulsion (Kodak)
and exposed in the dark at 47C for 6 weeks. After development, the
sections were counterstained with hematoxylin/eosin.
FIG. 2. Expression of activins and inhibin in normal and wounded
skin. 50 mg total cellular RNA from normal and wounded mouse
back skin were analyzed by RNase protection assay for expression RESULTS
of activin bA and bB chains and the inhibin a chain. The time in
days (d; 1, 3, 5, 7, 13) after injury is indicated at the top of each
mRNAs encoding activin, inhibin, activin receptors, andlane. 0d wound refers to nonwounded back skin. 1000 cpm of the
follistatin are differentially expressed in dermis and epi-hybridization probes was added to the lanes labeled ``probe.'' 50 mg
tRNA was used as a negative control. The gels were exposed for 2 dermis of mouse tail skin. To determine potential sites
days (bA and bB) and 7 days (inhibin a). An ethidium bromide stain of action of activins in the skin, we ®rst investigated the
of 1 mg of the same batch of RNA is shown below. The same set expression of these genes in the dermis and epidermis of
of RNAs was used for the protection assays of Figs. 2 and 3. mouse tails. This part of the skin was used since it is the
only area where the dermis can be separated from the epider-
mis. Using RNase protection assays (Fig. 1), activin bA
3±4 mm apart) were made on 20 mice per experiment by excising mRNA and inhibin a chain mRNA were detected at low
the skin and panniculus carnosus. The wounds were allowed to levels in the dermis but not in the epidermis. Expression of
dry in order to form a scab. Animals were sacri®ced and wounds activin bB mRNA was signi®cantly higher compared to bAfrom 4 animals were harvested 1, 3, 5, 7, and 13 days after
and a chain mRNA. It was found at highest levels in thewounding. An area of 7 mm diameter which includes the complete
dermis and at lower levels in the epidermis. Interestingly,epithelial margins was excised at each time point. A similar
two different protected fragments were obtained with RNAamount of skin from the backs of three nonwounded animals was
from the dermis but not from the epidermis, suggesting theused as a control. Wound tissue was immediately frozen in liquid
nitrogen and stored at 0707C until used for RNA isolation. presence of a shorter version of thebB chain in the dermis. In
RNA isolation and RNase protection analysis. To determine addition to activin and inhibin, all types of activin receptors
the expression of activin and activin receptors in the dermis and were found in the skin. The two different type I receptors
epidermis of mouse tail skin, total skin was ®rst separated from (ARI/Alk-2 and ARIB/Alk-4) (Attisano et al., 1993; ten Dijke
the underlying bone and subsequently incubated for 30 min at 377C et al., 1993; Carcamo et al., 1994) were expressed at equally
in 2 M NaBr. The dermis was then separated from the epidermis and
high levels in the skin, whereby ARI was primarily ex-immediately frozen in liquid nitrogen until used for RNA isolation.
pressed in the dermis and ARIB was found at highest levelsRNA isolation and RNase protection assays were performed as re-
in the epidermis. Two different protected fragments werecently described (Werner et al., 1992, 1993). All experiments were
obtained with the ARI probe, suggesting the existence ofrepeated with a different set of RNAs from an independent wound
healing experiment. two ARI receptor transcripts (Verschueren et al., 1995). The
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FIG. 3. Expression of activin receptors and follistatin in normal and wounded skin. 50 mg total cellular RNA from normal skin (0d
wound) and wounded skin were analyzed by RNase protection assay for expression of activin receptors and follistatin. The time after
injury is indicated on top of each lane. 0d refers to nonwounded back skin. 50 mg tRNA was used as a negative control. 1000 cpm of the
hybridization probes was added to the lanes labeled ``probe.'' The same set of RNAs was used for the protection assays of Figs. 2 and 3.
The gels were exposed for 10 hr (ARII), 15 hr (ARI, follistatin), or 48 hr (ARIB and ARIIB).
two different type II receptors (ARII and ARIIB) (Mathews declined and returned to the basal levels after completion
of skin repair (13 days after injury). The basal expression ofand Vale, 1991; Attisano et al., 1992) were expressed at
similar levels in both compartments of the skin. In addition activin bB mRNA was signi®cantly higher in nonwounded
skin compared to activin bA expression. After injury, expres-to the activin receptors, mRNA encoding the activin bind-
ing protein follistatin was found at low levels both in the sion of the bB gene also increased, although the induction
was not as strong as that seen for the bA gene (Fig. 2, seconddermis and in the epidermis. The generation of two different
protected fragments with the follistatin probe is most likely panel). Surprisingly, expression of activin bB mRNA had
still not declined at day 13 after wounding, suggesting adue to the existence of different forms of follistatin which
differ in their carboxy terminus (Michel et al., 1993). role of activin during the tissue remodelling phase of the
repair process. In contrast to the bA and bB chains, alpha-In summary these results show that activin, inhibin, and
a large variety of different activin receptors are differentially chain mRNA was hardly detectable in normal and wounded
skin and expression of this gene was not altered during theexpressed in the dermis and in the epidermis, suggesting
speci®c functions of the ligands in different compartments repair process (Fig. 2, third panel). The low expression of a
chain mRNA suggests that the bA and bB transcripts seenof the skin.
Large induction of activin expression during wound during wound healing give rise to different forms of activin
but not of inhibin.healing. To investigate the mRNA expression of activin
and inhibin during wound repair, we isolated RNA from Expression of activin receptors and follistatin in normal
and wounded skin. To investigate the mRNA expressionexcisional wounds at different time intervals after
wounding and performed RNase protection assays. Normal of activin receptors and follistatin in normal and wounded
skin, we performed RNase protection assays using the sameback skin from nonwounded mice served as a control. Simi-
larly as in tail skin (Fig. 1), mRNA encoding activin bA was RNA preparations as for the expression analysis of activin
and inhibin transcripts (see above). Similarly as in tail skin,expressed at very low levels in nonwounded back skin (Fig.
2, top panel). Within 24 hr after skin injury, a large induc- all known activin receptors and also follistatin were ex-
pressed in normal back skin (Fig. 3). A minor induction wastion of bA mRNA was observed. In fact, a ®rst induction
was already seen 15 hr after injury (data not shown) and seen for ARIB , and ARIIB mRNA expression declined after
injury. ARI, ARII, and follistatin expression levels werehighest expression levels of this gene were observed after
24 hr. Between Days 5 and 7 after injury expression levels identical in normal and wounded skin. Considering the dif-
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FIG. 4. Localization of Activin bA mRNA in a 5-day wound by in situ hybridization. A hematoxylin/eosin stain of half of the wound is
shown in (A). The arrow indicates the granulation tissue below the wound where the photograph in (B) was taken. In (A) the letters D,
H, HE, Es, and G indicate dermis, hair follicle, hyperproliferative epithelium, eschar, and granulation tissue. The silver grains produced
by the radioactive probe appear as black dots. Sections were counterstained with hematoxylin/eosin. Note the high expression of activin
bA in a certain population of cells in the granulation tissue below the eschar (magni®cations: A, 1001; B, 4001).
FIG. 5. Localization of activin bB mRNA in a 5-day wound by in situ hybridization. A hematoxylin/eosin stain of half of the wound is
shown in (A). The left arrow indicates the hyperproliferative epithelium where the photograph in (B) was taken. The right arrow indicates
the migrating epithelial tongue where the photograph in (C) was taken. In (A) the letters H, D, F, HE, ME, Es, and G indicate hair follicles,
dermis, fatty tissue, hyperproliferative epithelium, migrating epithelium, eschar, and granulation tissue. Note the high expression of
activin bB mRNA in keratinocytes of the hyperproliferative epithelium close to the wound and the migrating epithelial tongue below the
eschar (original magni®cations: A, 781; B and C, 3121).
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ferent exposure times of the protection assays, we can con- addition of TGFb3 had different effects on wound repair
and scar formation (Shah et al., 1995).clude that ARI was expressed at higher levels compared to
ARIB, and ARII was the predominant type II receptor in In contrast to TGFbs, a role of other members of the
TGFb superfamily in wound healing has not been demon-normal and particularly in wounded skin.
In situ hybridization ofbA and bB mRNA. To determine strated yet, although some of these genes are expressed in
embryonic or adult skin. These include several differentthe site of expression of the different forms of activin in
mouse wounds, we performed in situ hybridizations on 5- bone morphogenic proteins (for review, see Lyons et al.,
1991) and activin (Roberts et al., 1991; Roberts and Barth,day- and 3-day-old full-thickness wounds (Fig. 4 and data
not shown). At that time point after injury, a signi®cant 1994).
To determine a possible role of activin during woundamount of granulation tissue and hyperproliferative epithe-
lium had formed. As shown in Fig. 4B, high levels of bA healing, we have analyzed the mRNA expression of these
genes in normal skin and during the repair process. OurmRNA were detected in mesenchymal cells of the granula-
tion tissue adjacent to the hyperproliferative epithelium results show that all known members of the activin/activin
receptor family are expressed in normal and wounded skin,and below the eschar. No signi®cant levels of bA mRNA
were seen in other parts of the wound. The observation that suggesting multiple autocrine and paracrine actions of ac-
tivin in this tissue.only certain cells in the granulation tissue express this gene
suggests that these cells represent a distinct population that The most remarkable result was the extraordinary induc-
tion of activin bA, and to a lesser extent also bB expression,might have an important function in wound healing.
Similarly to the bA chain, expression of bB mRNA was within 15±24 hr after injury. The observed overexpression
of activin during wound healing correlates with ®ndingsalso restricted to a distinct cell population. This gene was
expressed at highest levels in keratinocytes of the hyper- from other researchers who detected a potent erythroid-
differentiation activity in wound ¯uid from severely burnedproliferative epithelium at the wound edge (Fig. 5B) and in
the migrating epithelial tongue (Fig. 5C). By contrast, bB keratinocyte-grafted patients (D. Huylebroeck, personal
communication). Since activin is a very ef®cient erythroid-mRNA was not expressed at detectable levels in mesenchy-
mal cells. differentiation factor (Eto et al., 1987), this activity could
be due to activin present in wound ¯uid. By contrast, theThese data show that the bA and bB chains are differen-
tially expressed in wounded skin, suggesting that activin B inhibin a chain was hardly detectable in normal and
wounded skin, indicating that the bA and bB transcripts giveis the predominant form in keratinocytes whereas activin
A is made primarily by cells in the mesenchyme. rise to activin but not to inhibin. High expression levels of
bA and bB mRNA where still observed several days after
injury, suggesting an important role of activin at all stages
of the repair process. By in situ hybridization of 3-day and
DISCUSSION 5-day-old wounds we detected bA mRNA exclusively in a
certain population of cells in the granulation tissue adjacent
to the hyperproliferative epithelium and below the eschar.The different members of the TGFb superfamily are
known to elicit a series of tissue-speci®c effects on cellular The cells that express this gene most likely represent a
distinct population of ®broblasts that might have an im-proliferation, differentiation, and metabolism. Therefore,
they have the properties expected of wound cytokines. In- portant role in wound repair. This hypothesis is supported
by the detection of high levels ofbA mRNA in exponentiallydeed, a series of in vitro and in vivo studies have demon-
strated an important role of TGFb1, b2, and b3 in skin growing but not in quiescent ®broblasts in vitro (G.H., un-
published data). The localization of activin bA mRNA inrepair. Exogenous TGFb1 is a potent stimulator of ®broblast
proliferation and it induces extracellular matrix production mesenchymal cells during wound healing is reminiscent to
the situation seen in embryonic skin in which bA mRNAby epithelial, mesenchymal, and endothelial cells (for re-
view, see Pittelkow et al., 1991). Furthermore, it stimulates could be detected at signi®cant levels in the dermal layers
(Roberts et al., 1991; Roberts and Barth, 1994). This repre-angiogenesis and wound reepithelialization in vivo (Roberts
et al., 1986; Hebda, 1988), although it inhibits endothelial sents another example for the known similarities between
developmental and repair processes. In contrast to bAand epithelial cell proliferation in vitro (Baird and Durkin,
1986; Frater-SchroÈ der et al., 1986; Shipley et al., 1986; Pit- mRNA, bB mRNA was found at highest levels in migrating
and proliferating keratinocytes at the wound edge. Thesetelkow et al., 1988). Finally, TGFb1 is an important modu-
lator of keratinocyte differentiation (Mansbridge and Hana- data suggest that activin A is the most abundant form of
activin in the mesenchyme, whereas keratinocytes prefer-walt, 1988; Choi and Fuchs, 1990).
Recent studies have demonstrated a differential expres- entially synthesize activin B. The biological importance of
this differential expression is currently unknown, since nosion of TGFb1, b2, and b3 during wound healing (Levine
et al., 1993), suggesting unique functions of the different differences in the activity of various types of activin have
been demonstrated in vitro.types of TGFb. This hypothesis was con®rmed by a series
of in vivo studies, in which neutralizing antibodies against The reason for the strong induction of activin expression
after injury has not yet been determined. However, prelimi-TGFb1 and 2, or exogenous addition of TGFb3 in which
neutralizing antibodies against TGFb1 and 2 or exogenous nary in vitro studies from our laboratory suggest that serum
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cells and are regulated on their differentiation. Development 117,growth factors which are released upon hemorrhage and
711±723.macrophage-derived proin¯ammatory cytokines might be
Albano, R. M., Arkell, R., Beddington, R. S. P., and Smith, J. C.responsible for the induction, since these factors are potent
(1994). Expression of inhibin subunits and follistatin during post-inducers of activin expression in cultured ®broblasts and
implantation mouse development; decidual expression of activinkeratinocytes (G.H., unpublished data).
and expression of follistatin in primitive streak, somites and hin-
In addition to activin, all known types of activin receptors dbrain. Development 120, 803±813.
were present in normal and wounded skin. The predomi- Attisano, L., Wrana, J. L., Cheifetz, S., and Massague, J. (1992).
nant type II receptor during wound healing was ARII, Novel activin receptors: Distinct genes and alternative mRNA
whereas ARIIB mRNA levels signi®cantly declined after in- splicing generate a repertoire of serine/threonine kinase recep-
tors. Cell 68, 97±108.jury. This is similar to the situation seen during embryonic
Attisano, L., Carcamo, J., Ventura, F., Weis, F. M. B., Massague, J.,mouse development, in which ARII is expressed in the skin,
and Wrana, J. L. (1993). Identi®cation of human activin and TGFbwhereas ARIIB is not (Feijen et al., 1994). In contrast to
type I receptors that form heteromeric kinase complexes withactivin, no signi®cant induction of activin receptor expres-
type II receptors. Cell 75, 671±680.sion was seen during the repair process. Thus, regulation of
Baird, A., and Durkin, T. (1986). Inhibition of endothelial cell prolif-activin function during wound healing seems to be regu-
eration by type b-transforming growth factor: Interactions with
lated by increased expression of the ligands but not of the acidic and basic ®broblast growth factors. Biochem. Biophys. Res.
receptors. A similar type of regulation has recently been Commun. 138, 476±482.
demonstrated for other growth factors, including ®broblast Carcamo, J., Weis, F. M. B., Ventura, F., Wieser, R., Wrana, J. L.,
growth factors (Werner et al., 1992). Preliminary in situ Attisano, L., and Massague, J. (1994). Type I receptors specify
growth-inhibitory and transcriptional responses to transforminghybridization experiments revealed expression of activin re-
growth factor b and activin. Mol. Cell. Biol. 14, 3810±3821.ceptors both in mesenchymal and epithelial cells in the
Choi, Y., and Fuchs, E. (1990). TGF-beta and retinoic acid: Regula-wound, indicating multiple autocrine and paracrine actions
tors of cell growth and modi®ers of differentiation in humanof activin in wounded skin.
epidermal cells. Cell Regul. 1, 791±809.The function of activin in wounded skin is presently un-
Esch, F. S., Shimasaki, S., Mercado, M., Cooksey, K., Ling, N., Ying,known. Since activins are members of the transforming
S., Ueno, N., and Guilleman, R. (1987). Structural characteriza-
growth factor b superfamily one might speculate about sim- tion of follistatin: A novel follicle-stimulating hormone release-
ilar effects of activin and TGFb. Indeed, preliminary in vitro inhibiting polypeptide from the gonad. Mol. Endocrinol. 1, 849±
studies from our laboratory suggest a role of activin in con- 855.
nective tissue formation and keratinocyte differentiation Feijen, A., Goumans, M. J., and van den Eijnden-van Raaij, A. J.
M. (1994). Expression of activin subunits, activin receptors and(G.H. unpublished data). Furthermore, mice de®cient in fol-
follistatin in postimplantation mouse embryos suggests speci®clistatin have hyperkeratotic skin, as indicated by thickened
developmental functions for different activins. Developmentgranular and stratum corneum layers (Matzuk et al., 1995b).
120, 3621±3637.This ®nding provides further evidence for a role of activin
Eto, Y., Tsuji, T., Takezawa, S., Takano, T., Yokogawa, Y., andand activin binding proteins in the differentiation of the
Shibai, H. (1987). Puri®cation and characterization of erythroidepidermis. Future tissue culture experiments as well as
differentiation factor (EDF) isolated from human leukemia cell
transgenic mouse studies will help to elucidate the function line, THP-1. Biochem. Biophys. Res. Commum. 142, 1095±1103.
of activins in normal skin and particularly during wound Frater-SchroÈder, M., Muller, G., Birchmeier, W., and BoÈ hlen, P.
repair. (1986). Transforming growth factor-beta inhibits endothelial cell
proliferation. Biochem. Biophys. Res. Commun. 137, 295±302.
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